Rocket Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RCKT and other ETFs, options, and stocks.About RCKT
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms.
CEOGaurav D. Shah
CEOGaurav D. Shah
Employees299
Employees299
HeadquartersCranbury, New Jersey
HeadquartersCranbury, New Jersey
Founded1999
Founded1999
Employees299
Employees299
RCKT Key Statistics
Market cap330.08M
Market cap330.08M
Price-Earnings ratio-1.36
Price-Earnings ratio-1.36
Dividend yield—
Dividend yield—
Average volume2.07M
Average volume2.07M
High today$3.11
High today$3.11
Low today$2.98
Low today$2.98
Open price$3.03
Open price$3.03
Volume2.94M
Volume2.94M
52 Week high$15.01
52 Week high$15.01
52 Week low$2.19
52 Week low$2.19
Stock Snapshot
With a market cap of 330.08M, Rocket Pharmaceuticals(RCKT) trades at $3.04. The stock has a price-to-earnings ratio of -1.36.
On 2025-11-17, Rocket Pharmaceuticals(RCKT) stock traded between a low of $2.98 and a high of $3.11. Shares are currently priced at $3.04, which is +2.2% above the low and -2.3% below the high.
Rocket Pharmaceuticals(RCKT) shares are trading with a volume of 2.94M, against a daily average of 2.07M.
During the past year, Rocket Pharmaceuticals(RCKT) stock moved between $2.19 at its lowest and $15.01 at its peak.
During the past year, Rocket Pharmaceuticals(RCKT) stock moved between $2.19 at its lowest and $15.01 at its peak.
Analyst ratings
47%
of 15 ratingsBuy
46.7%
Hold
46.7%
Sell
6.7%
People also own
Based on the portfolios of people who own RCKT. This list is generated using Robinhood data, and it’s not a recommendation.